DuPont Capital Management Corporation »

Liminatus Pharma shares owned by DuPont Capital Management Corporation

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by DuPont Capital Management Corporation from 13F filings

Historical chart of DuPont Capital Management Corporation investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by DuPont Capital Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by DuPont Capital Management Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $925 6.3k 0.15
2025-06-30 $1.5k 6.3k 0.24

More positions owned by DuPont Capital Management Corporation

Nvidia Corp Common Stock Usd.001 (NVDA)
Microsoft Corp Common Stock Usd.00000625 (MSFT)
Apple Common Stock Usd.00001 (AAPL)
Amazon.com Common Stock Usd.01 (AMZN)
Alphabet Inc Cl C Common Stock Usd.001 (GOOG)
Meta Platforms Inc Class A Common Stock Usd.000006 (META)
Vanguard Ftse Emerging Markets Vanguard Ftse Emerging Marke (VWO)
Jpmorgan Chase Common Stock Usd1.0 (JPM)
Broadcom Common Stock (AVGO)
Mastercard Inc A Common Stock Usd.0001 (MA)
Taiwan Semiconductor Sp Adr (TSM)
Utilities Select Sector Spdr F Utilities Select Sector Spdr (XLU)
Netflix Common Stock Usd.001 (NFLX)
Bank Of America Corp Common Stock Usd.01 (BAC)
Coca Cola Co/the Common Stock Usd.25 (KO)

View all positions for DuPont Capital Management Corporation

Top funds holding Liminatus Pharma

Clear Street
Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
Nomura Holdings
Falcon Edge Capital
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital

View all funds holding Liminatus Pharma